• Our Offering
    • small molecules

      • Preclinical Services
      • IND/Clinical Supply
      • Drug Substance
      • API
      • Advanced Intermediate
      • Highly Potent API
      • ADC Payload
      • Drug Product
      • Particle Engineering
      • Bioavailability Enhancement
      • Oral Solid
      • Inhalation
      • Parenteral
    • biologics

      • Preclinical Offering
      • Expression Technologies
      • Discovery Services
      • Drug Substance
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Ibex® Solutions
      • Drug Product
      • Parenteral
    • cell & gene

      • Allogeneic Cell Therapy
      • iPSC Manufacturing
      • Exosomes
      • Cell Based Immunotherapies
      • Autologous Cell Therapy
      • Cell Based Immunotherapies
      • Viral Vectors
      • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Support
      • Tissue Acquisition
      • Products
      • Cocoon® Platform
    • bioscience

      • Primary & Stem Cells
      • Bioprocessing Media
      • CellBio Services
      • Culture Media & Reagents
      • ADME & Toxicology
      • Transfection
      • Cell Assays & Analysis
      • Electrophoresis
      • Informatics – Paperless Solutions
      • QC & Endotoxin Detection
      • Automated Sterile Sampling
    • capsules

      • Immediate Release
      • Modified Release
      • Vegetarian
      • Inhalation
      • Over the Counter (OTC)
      • IND / Clinical Supply
      • Equipment
  • Resources
      • technologies & products

        We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

      • regulatory support

        In close collaboration with you, Lonza Regulatory Affairs provide a CMC dossier suitable to the stage of clinical development of your product manufactured by Lonza.

      • technical support

        The collective expertise of our multi-disciplinary team in protein expression and production processes can help you get the most from our industry-leading technologies.

      • knowledge center

        Gather additional industry and technical information from our repository of resources and educational content.

  • About Us
    • about us

      Delivering the medicines of tomorrow today

    • careers

      Find opportunities

    • events

      the next conversation...

    • locations

      View our locations

    • news

      View press releases

  • Contact Us
Our Offering
small molecules
  • Preclinical Services
  • IND/Clinical Supply
  • Drug Substance
  • API
  • Advanced Intermediate
  • Highly Potent API
  • ADC Payload
  • Drug Product
  • Particle Engineering
  • Bioavailability Enhancement
  • Oral Solid
  • Inhalation
  • Parenteral
biologics
  • Preclinical Offering
  • Expression Technologies
  • Discovery Services
  • Drug Substance
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Ibex® Solutions
  • Drug Product
  • Parenteral
cell & gene
  • Allogeneic Cell Therapy
  • iPSC Manufacturing
  • Exosomes
  • Cell Based Immunotherapies
  • Autologous Cell Therapy
  • Cell Based Immunotherapies
  • Viral Vectors
  • Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Support
  • Tissue Acquisition
  • Products
  • Cocoon® Platform
bioscience
  • Primary & Stem Cells
  • Bioprocessing Media
  • CellBio Services
  • Culture Media & Reagents
  • ADME & Toxicology
  • Transfection
  • Cell Assays & Analysis
  • Electrophoresis
  • Informatics – Paperless Solutions
  • QC & Endotoxin Detection
  • Automated Sterile Sampling
capsules
  • Immediate Release
  • Modified Release
  • Vegetarian
  • Inhalation
  • Over the Counter (OTC)
  • IND / Clinical Supply
  • Equipment
Resources
technologies & products
regulatory support
technical support
knowledge center
About Us
about us
careers
events
locations
news
Contact Us

Our latest news and announcements

    • Knowledge Center
    • Offerings
    • About Us
    • Technologies & Products
    • Contact us
  • About Us
    • Locations
    • Job search
    • Events
  • News
Filter by News Category
Financials (3) General (3) Acquisitions (1)
Filter by Year
2021 (1) 2020 (2)
Filter by Language
English (3)
FinancialsX
EnglishX
Showing 1‐3 of 3
results per page
19 Jan 2021
NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology...
27 Aug 2020
Lonza Prices CHF 150 Million Straight-Bond with a 0.350% Coupon
18 May 2020
Moncef Slaoui to Step Down as Member of the Board of Directors of Lonza Group
Basel, Switzerland, 18 May 2020 – Dr Moncef Slaoui has decided to step down from his position as a member of the Lonza Group Board of Directors,...
About Us
  • Careers
  • Events
  • Locations
  • News
Resources
  • Knowledge Center
  • Technologies and Products
  • Technical Support
  • Regulatory Support
Terms
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
www.lonza.com
© 2021 Lonza. All Rights Reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.